AOLS Financials 07/15/2014 20:50:20 Aeolus Pharma

AOLS Financials 07/15/2014 20:50:20
Aeolus Pharmaceuticals, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 3,928 7,293 4,821 -
Cost of Revenue - - - -
Gross Profit 3,928 7,293 4,821 -
Operating Expenses
Research and Development 3,360 6,468 5,055 1,690
Sales, General and Admin. 3,266 3,196 3,668 1,954
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,698) (2,371) (3,902) (3,644)
Income From Continuing Operations
Add'l Income/Expense Items (510) 4,069 4,222 (21,347)
Earnings Before Interest and Tax (3,208) 1,698 320 (24,991)
Interest Expense - - 21 878
Earnings Before Tax (3,208) 1,698 299 (25,869)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,208) 1,698 299 (25,869)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,208) 1,698 299 (25,869)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,208) 1,698 299 (25,869)